Publication

Byline

Sun Pharma signs deal with US government to reduce drug prices

New Delhi, Sept. 1 -- Drug major Sun Pharmaceutical Industries has signed a deal with the US government to lower prices of its innovative drugs in the US, in line with the lowest prices paid by other ... और पढ़ें


Tata Capital Healthcare Fund leads $30 million investment in Tenet Diagnostics

New Delhi, Aug. 17 -- Tata Capital Healthcare Fund (TCHF) and Swiss investor Blue Earth Capital AG on Monday announced a $30 million investment in Tenet Diagnostics for an undisclosed equity stake. Th... और पढ़ें


Apollo Hospitals beats estimates for Q1FY27, net profit up 34%

New Delhi, Aug. 12 -- Apollo Hospitals Enterprise Ltd beat street estimates for the June quarter as high speciality volumes continued to boost growth, and the hospital chain continued its capacity exp... और पढ़ें


US generics tariffs more negotiation tactic than real threat: Biocon's Kiran Mazumdar-Shaw

New Delhi, Aug. 7 -- Biocon is not rushing to react to proposed US tariffs on generic drugs in its largest market as it sees the move as a negotiation tactic rather than a real threat, executive chair... और पढ़ें


Metropolis ramps up small-town presence to capture shift toward organized healthcare

New Delhi, Aug. 6 -- Diagnostics major Metropolis Healthcare is accelerating its expansion into India's tier-II and tier-III markets, capitalizing on a multi-year investment push designed to capture a... और पढ़ें


US generics drag weighs on Sun Pharma

Mumbai, Aug. 1 -- Sun Pharmaceutical Industries, India's biggest drugmaker by market capitalization, missed Street expectations in the June quarter as weakness in its US generics business weighed on p... और पढ़ें


Sun Pharma misses Q1 estimates as US generics drag offsets India growth

New Delhi, July 31 -- Sun Pharmaceutical Industries, India's largest drugmaker market capitalization, missed Street expectations in the June quarter as weakness in its US generics business weighed on ... और पढ़ें


Domestic focus powers Torrent, Mankind in June quarter

New Delhi, July 30 -- India's domestic pharmaceutical market is emerging as a bright spot for drugmakers, helping companies with a strong local franchise outpace peers exposed to the increasingly chal... और पढ़ें


Mint Explainer: How can Indian drugmakers blunt the impact of Trump's generic tariffs?

New Delhi, July 26 -- Last week, US President Donald Trump announced a phased tariff plan for low-cost generic drugs, with the aim of bringing manufacturing back to the US. While many believe the plan... और पढ़ें


Cipla expects US sales ramp-up in FY27, maintains full year guidance

New Delhi, July 23 -- Cipla, which posted its financial results for the June quarter on Thursday, saw its profits dip 39% over softer US sales. However, the company expects sequential sales momentum i... और पढ़ें